Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | Mtg2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MTG2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | increases expression | ISO | Mtg2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of MTG2 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mtg2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MTG2 mRNA | CTD | PMID:21570461 | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of MTG2 mRNA | CTD | PMID:30851411 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MTG2 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MTG2 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Mtg2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MTG2 mRNA | CTD | PMID:36041667 | acrylamide | decreases expression | ISO | Mtg2 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of MTG2 mRNA | CTD | PMID:28959563 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of MTG2 mRNA | CTD | PMID:33212167 | arsane | affects expression | EXP | | 6480464 | Arsenic affects the expression of MTG2 mRNA | CTD | PMID:18414638 | arsenic atom | affects expression | EXP | | 6480464 | Arsenic affects the expression of MTG2 mRNA | CTD | PMID:18414638 | bisphenol A | decreases expression | ISO | Mtg2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MTG2 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | Mtg2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MTG2 mRNA | CTD | PMID:36041667 | bisphenol A | increases methylation | ISO | Mtg2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of MTG2 gene | CTD | PMID:28505145 | bisphenol F | multiple interactions | ISO | Mtg2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MTG2 mRNA | CTD | PMID:36041667 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MTG2 gene] | CTD | PMID:28238834 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MTG2 mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | ISO | Mtg2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of MTG2 mRNA | CTD | PMID:21266533 | folic acid | multiple interactions | ISO | Mtg2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MTG2 mRNA | CTD | PMID:22206623 | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of MTG2 protein | CTD | PMID:37730182 | hydrogen peroxide | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of MTG2 protein | CTD | PMID:18951874 | hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of MTG2 mRNA | CTD | PMID:18951874 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MTG2 mRNA | CTD | PMID:28628672 | ketamine | decreases expression | ISO | Mtg2 (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of MTG2 mRNA | CTD | PMID:20080153 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MTG2 mRNA | CTD | PMID:19710929 | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of MTG2 mRNA | CTD | PMID:30851411 | theophylline | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of MTG2 protein | CTD | PMID:18951874 | vinclozolin | affects expression | ISO | Mtg2 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of MTG2 mRNA | CTD | PMID:19015723 | vinclozolin | decreases methylation | ISO | Mtg2 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased methylation of MTG2 gene | CTD | PMID:31079544 | vincristine | increases expression | EXP | | 6480464 | Vincristine results in increased expression of MTG2 mRNA | CTD | PMID:23649840 | |